{
    "nct_id": "NCT00737893",
    "official_title": "Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: a Prospective Randomized Controlled Trial (ERECT)",
    "inclusion_criteria": "* Patient eligibility consists of men 40 to 65 years of age\n* Localized prostate cancer\n\n  * clinical stage T2a or lower\n  * Gleason grade of 3+4 or 3+3\n  * prostate specific antigen (PSA) < 10\n* Scheduled to undergo curative prostatectomy applying bilateral nerve-sparing procedure, with intact pre-surgical erectile function\n* International Index of Erectile Function-5 (IIEF-5) score of 22-25.\n* The patient has a sexual partner, of at least 6 months.\n* The patient's pre-surgical hematocrit is â‰¤ 48.\n* The patient is willing to attempt intercourse at least 5 times per month following recovery from surgery.\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 40 Years\nMust have maximum age of 65 Years",
    "exclusion_criteria": "* The patient has known penile deformity or a history of Peyronie's disease.\n* The patient has planned pre or post operative androgen therapy.\n* The patient has planned pre or post operative radiation therapy.\n* The patient is on anticoagulation therapy.\n* The patient has a history of sickle cell anemia.\n* The patient has a history of high or low blood pressure that is not controlled.\n* The patient is taking medications called \"nitrates\"\n* The patient has a history of heart problems such as angina, heart failure, irregular heartbeats, or myocardial infarction\n* The patient has a history of history of drug or alcohol abuse.\n* The patient currently smokes or has a 20 pack/year history of cigarette smoking.\n* The patient has a history of acute or chronic depression\n* The patient has a history liver problems, or kidney problems.\n* The patient has a history of retinitis pigmentosa or severe vision loss, including a condition called NAION, Nonarteritic Anterior Ischemic Optic Neuropathy.\n* The patient has a history of spinal trauma or surgery to the brain or spinal cord.\n* The patient has contraindications to the use of phosphodiesterase type 5 (PDE 5) inhibitors.\n* Patient is currently participating in another clinical investigation that would serve as a contraindication to administering erythropoietin.",
    "miscellaneous_criteria": ""
}